Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kawasaki disease.

Jane W Newburger1, David R Fulton

  • 1Department of Cardiology at Children's Hospital, Boston, Massachusetts 02115, USA. jane.newburger@cardio.chboston.org

Current Opinion in Pediatrics
|September 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apixaban for the treatment of venous thromboembolic events in paediatric patients: an open-label, multicentre, randomised, controlled descriptive trial.

The Lancet. Haematology·2026
Same author

Association of Fetal Cerebrovascular Resistance and Neurodevelopment in Congenital Heart Disease: A Physiology-Based Analysis.

Prenatal diagnosis·2026
Same author

Validation of a Briefer Anxiety Screening Tool for Use in Pediatric Cardiology Clinics.

JACC. Advances·2026
Same author

Scoring gene importance by interpreting single-cell foundation models.

Nature biotechnology·2026
Same author

Geospatial Access to Pediatric Cardiac and Cardiac-Surgical Services by Neighborhood-Level Determinants of Health.

Journal of the American Heart Association·2026
Same author

Rare <i>KDR</i> Variants Define a Distinct Genetic Contribution to Congenital Heart Disease.

Circulation. Genomic and precision medicine·2026
Same journal

For health, for beauty, or both? navigating trends as adolescent clinicians.

Current opinion in pediatrics·2026
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
See all related articles

Kawasaki disease, a childhood vasculitis, can lead to heart issues. Intravenous immune globulin therapy is effective in preventing coronary aneurysms, though resistant cases require further research.

Area of Science:

  • Pediatric rheumatology
  • Cardiovascular pathology
  • Immunology

Background:

  • Kawasaki disease is a leading cause of acquired heart disease in children in the US.
  • It presents as an acute vasculitis with characteristic clinical signs.
  • Coronary artery aneurysms are a significant complication, potentially leading to severe cardiac events.

Purpose of the Study:

  • To review key data on Kawasaki disease etiology, pathogenesis, and treatment.
  • To highlight recent publications and advancements in the field.
  • To discuss long-term outcomes and management strategies.

Main Methods:

  • Comprehensive literature review of recent publications.
  • Analysis of epidemiological data on acquired heart disease in children.

Related Experiment Videos

  • Synthesis of current understanding of disease mechanisms and therapeutic responses.

    • Main Results:

    • Intravenous immune globulin (IVIG) therapy is effective in reducing coronary aneurysms in acute Kawasaki disease.
    • The cause of Kawasaki disease remains unknown.
    • Treatment for IVIG-resistant cases is an area of ongoing research and clinical debate.

    Conclusions:

    • Kawasaki disease management and long-term outcomes are closely linked to coronary artery status.
    • Continued research is vital for understanding and treating resistant cases.
    • Effective acute-phase treatment significantly impacts pediatric cardiovascular health.